Medical Experts Allowed In Pfizer Securities Suit
A federal judge has allowed Pfizer Inc. and a class of plaintiffs suing it for securities fraud in connection with the marketing of its anti-inflammatory drugs Celebrex and Bextra to introduce...To view the full article, register now.
Already a subscriber? Click here to view full article